These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1910125)

  • 41. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
    Glas-Greenwalt P; Kant KS; Dosekun A; Frazier J; Allen C; Pollak VE
    J Lab Clin Med; 1985 Jan; 105(1):99-107. PubMed ID: 3871465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
    Idell S
    Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
    Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abnormalities of pathways of fibrin turnover in the human pleural space.
    Idell S; Girard W; Koenig KB; McLarty J; Fair DS
    Am Rev Respir Dis; 1991 Jul; 144(1):187-94. PubMed ID: 2064128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The fibrinolytic system in pre-eclampsia.
    Gow L; Campbell DM; Ogston D
    J Clin Pathol; 1984 Jan; 37(1):56-8. PubMed ID: 6423699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.
    Glas-Greenwalt P; Hall JM; Panke TW; Kant KS; Allen CM; Pollak VE
    J Lab Clin Med; 1986 Nov; 108(5):415-22. PubMed ID: 2430036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of TGF-beta and TNF-alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial cells.
    Idell S; Kumar A; Zwieb C; Holiday D; Koenig KB; Johnson AR
    Am J Physiol; 1994 Dec; 267(6 Pt 1):L693-703. PubMed ID: 7810674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrinolytic therapy with streptokinase for established experimental glomerulonephritis.
    Tipping PG; Holdsworth SR
    Nephron; 1986; 43(4):258-64. PubMed ID: 3736736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The vascular wall and fibrinolysis--physiologic aspects].
    Binder BR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):151-63. PubMed ID: 2427396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation.
    Matucci-Cerinic M; Lotti T; Lombardi A; Pignone A; Iannone F; Beneforti E; Cinotti S; Morfini M; Caignoni M
    Int J Dermatol; 1990 Nov; 29(9):644-8. PubMed ID: 2125582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma.
    Semeraro N; Montemurro P; Giordano P; Santoro N; De Mattia D; Colucci M
    Thromb Haemost; 1994 Jul; 72(1):54-7. PubMed ID: 7974375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibrinolytic response to tumor necrosis factor in healthy subjects.
    van der Poll T; Levi M; Büller HR; van Deventer SJ; de Boer JP; Hack CE; ten Cate JW
    J Exp Med; 1991 Sep; 174(3):729-32. PubMed ID: 1714936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
    Trübestein G; Popov S; Wolf H; Welzel D
    Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
    Voss R; Matthias FR; Borkowski G; Reitz D
    Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrinolytic activity in renal venous blood in man.
    Schrader J; Neuhaus KL; Tebbe U; Köstering H; Scheler F
    Klin Wochenschr; 1986 Jul; 64(13):587-9. PubMed ID: 3747416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgA nephritis associated with plasminogen abnormalities.
    Kitamoto Y; Nakayama M; Sakata Y; Taguchi H; Kuwahara K; Arima S; Ikezaki N; Nakano T; Kiyama S; Tomita M
    Clin Nephrol; 1990 Feb; 33(2):61-5. PubMed ID: 2311307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.